T1EV34.SA Teva Pharmaceutical Industries Limited

Healthcare Drug Manufacturers - Specialty & Generic Sao Paulo Exchange
117.00 BRL
Close of Nov 5, 2026
63.70 117.00
Market cap
BRL 273B
P/E
104.5x
P/B
6.47x
ROE
-5.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is T1EV34.SA undervalued?

Graham number

The Graham number of Teva Pharmaceutical Industries Limited cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Teva Pharmaceutical Industries Limited fundamental analysis

No fundamental analysis for Teva Pharmaceutical Industries Limited yet.

Teva Pharmaceutical Industries Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and …

Full company profile